Acrivon Therapeutics Statistics
NASDAQ: ACRVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.92+0.05 (+2.67%)
Market open · Delayed 15 min · as of Oct 9, 11:37 AM ET
Acrivon Therapeutics by the numbers
Acrivon Therapeutics has a market capitalization of $82.3 million based on 42.85M shares outstanding. With trailing EPS of $-1.88, Acrivon Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.7% below its 50-day average and 6.2% above its 200-day average.
Average daily trading volume is 356.18K shares, or about $683,856 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACRV valuation vs. peer median
| Metric | ACRV | Peer median | Difference |
|---|---|---|---|
| Market cap | $82.28M | $76.93M | +7% |
| Avg. volume | 356.18K | 177.50K | +101% |
Peer median across 8 companies: RFL, PDSB, TELO, NTHI, MNOV, LFVN, HRTX, INCR.
Valuation
- Market cap
- $82.28M
- EPS (TTM)
- $-1.88
- Shares outstanding
- 42.85M
Price and trading
- Previous close
- 1.87
- Open
- 1.88
- Day range
- 1.86 – 1.93
- 52-week range
- 1.27 – 3.56
- 52-week change
- -0.53%
- Beta
- —
- Volume
- 43.28K
- Average volume
- 356.18K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2025
Additional statistics
- Market Cap
- 82.28M
- Forward Pe
- -1.17
- Eps
- -1.88
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.56
- Week52 Low
- 1.27
- Avg Volume
- 356.18K
- Shares Outstanding
- 42.85M
- Ma50
- 1.95
- Ma200
- 1.81
- Earnings Date
- Aug 14, 2025
- Pct From52w High
- -46.07%
- Pct From52w Low
- 51.18%